XML 18 R4.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Revenue:    
Licensing revenue $ 250,000 $ 100,000
Expenses:    
Research and development 388,841 15,847,722
General and administrative 8,079,861 12,502,042
Depreciation and amortization 29,423 106,989
Total expenses 8,498,125 28,456,753
Loss before other income (expense) (8,248,125) (28,356,753)
Other income (expense):    
Interest income 355,558 365,584
Interest expense (1,715,733) (3,831,211)
Other income (expense), net 2,676 6,998
Gain on warrant liabilities 527,025 1,367,777
Loss before provision for income taxes (9,078,599) (30,447,605)
Provision for income taxes (800) (800)
Loss from continuing operations (9,079,399) (30,448,405)
Discontinued operations (Note 3) (3,634,209) (4,538,027)
Net loss $ (12,713,608) $ (34,986,432)
Basic and diluted loss per share    
Continuing operations $ (0.29) $ (1.27)
Discontinued operations (0.12) (0.19)
Total basic and diluted loss per share $ (0.41) $ (1.46)
Basic and diluted weighted average shares outstanding 30,947,650 24,042,293